CD274 and neoplasm: Interestingly, Chovanec et al. performed a combinatorial survival analysis involving the systemic immune-inflammation index (SII) based on platelet, neutrophil and lymphocyte counts and PD-L1 expression on tumor infiltrating lymphocytes (TILs).